Commentary: Guideline for male testosterone therapy: a regulatory perspective.
Shames
Daniel
D
Division of Reproductive and Urologic Products, Center for Drug Evaluation and Research. U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, USA. daniel.shames@fda.hhs.gov
Gassman
Audrey
A
Handelsman
Harry
H
D000728:Androgens / Q000627:therapeutic use*; D004704:Endocrinology / Q000592:standards*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D013739:Testosterone / Q000627:therapeutic use*
D000728:Androgens; D013739:Testosterone